Recursion Pharmaceuticals, Inc.
RXRX
Revenue
35.54M
▲30.36M▲586.72%
3 Months ChangeAssets
1.47B
▲74.60M▲5.33%
3 Months ChangeLiabilities
343.27M
▼-9.31M▼-2.64%
3 Months ChangeFree Cash Flow
-133.79M
▼-24.84M▼-22.80%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-25
Form 8-K
ID: 0001601830-26-000038
2026-01-12
Form 8-K
ID: 0001601830-26-000002
2025-12-08
Form 8-K
ID: 0001601830-25-000174
2025-11-26
Form 8-K
ID: 0001601830-25-000172
2025-11-05
Form 10-Q
ID: 0001601830-25-000166
2025-11-05
Form 8-K
ID: 0001601830-25-000164
2025-10-29
Form 8-K
ID: 0001601830-25-000152
2025-08-05
Form 10-Q
ID: 0001601830-25-000127
2025-08-05
Form 8-K
ID: 0001601830-25-000126
2025-07-08
Form 8-K
ID: 0001193125-25-156440